Kinsale Capital Group, Inc. Bristol Myers Squibb CO Transaction History
Kinsale Capital Group, Inc.
- $406 Million
- Q1 2025
A detailed history of Kinsale Capital Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kinsale Capital Group, Inc. holds 132,090 shares of BMY stock, worth $6.36 Million. This represents 1.98% of its overall portfolio holdings.
Number of Shares
132,090
Previous 111,270
18.71%
Holding current value
$6.36 Million
Previous $6.29 Million
28.02%
% of portfolio
1.98%
Previous 1.69%
Shares
9 transactions
Others Institutions Holding BMY
# of Institutions
2,813Shares Held
1.6BCall Options Held
29.6MPut Options Held
28.2M-
Vanguard Group Inc Valley Forge, PA191MShares$9.22 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.64 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.21 Billion0.52% of portfolio
-
State Street Corp Boston, MA95.1MShares$4.58 Billion0.22% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.2 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $102B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...